Emma Lefrançais
- Immunology top 1%
- Surgery top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Hematology top 2%
- Co-authors
- Jean‐Philippe GirardMark R. LooneyCorinne CayrolBeñat MallaviaStéphane RogaEmilie MireyCarolyn S. CalfeeHanjing Zhuo
- Topics
- Eosinophilic Esophagitis (7 papers)IL-33, ST2, and ILC Pathways (7 papers)Platelet Disorders and Treatments (3 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Emma Lefrançais
14 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 1.8k
- Surgery 912
- Molecular Biology 440
- Pulmonary and Respiratory Medicine 427
- Hematology 390
Countries citing papers authored by Emma Lefrançais
This map shows the geographic impact of Emma Lefrançais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Lefrançais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Lefrançais more than expected).
Fields of papers citing papers by Emma Lefrançais
This network shows the impact of papers produced by Emma Lefrançais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Lefrançais. The network helps show where Emma Lefrançais may publish in the future.
Co-authorship network of co-authors of Emma Lefrançais
This figure shows the co-authorship network connecting the top 25 collaborators of Emma Lefrançais. A scholar is included among the top collaborators of Emma Lefrançais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Lefrançais. Emma Lefrançais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 15 | |
| 3 | 12 | |
| 4 | 29 | |
| 5 | 39 | |
| 6 | 42 | |
| 7 | 58 | |
| 8 | 340 | |
| 9 | The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitorsbreakdown → | 767 |
| 10 | 53 | |
| 11 | 290 | |
| 12 | IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin Gbreakdown → | 449 |
| 13 | 91 | |
| 14 | 182 | |
| 15 | 387 |
About Emma Lefrançais
Emma Lefrançais is a scholar working on Immunology, Hematology and Internal Medicine, having authored 15 papers that have together received 2.8k indexed citations. Recurring topics across this work include Eosinophilic Esophagitis (7 papers), IL-33, ST2, and ILC Pathways (7 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Immunology (1.8k citations), Hematology (390 citations) and Internal Medicine (85 citations). Emma Lefrançais has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Philippe Girard, Mark R. Looney, Corinne Cayrol, Beñat Mallavia, Stéphane Roga, Emilie Mirey, Carolyn S. Calfee, Hanjing Zhuo, Nathalie Ortéga and Mélanie Pichery. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.